Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

38.000
-2.600-6.40%
Volume:1.67M
Turnover:63.85M
Market Cap:9.39B
PE:294.97
High:39.920
Open:39.520
Low:36.920
Close:40.600
52wk High:52.200
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.29
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.129
ROE:0.82%
ROA:-0.80%
PB:1.61
PE(LYR):294.97
PS:6.49

Loading ...

CansinoBio Surges Nearly 9% in Morning Trade Following Strategic mRNA Cancer Vaccine Collaboration

Deep News
·
Sep 23

HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%

Tiger Newspress
·
Sep 23

Movement Alert|CANSINOBIO Rises 5.03% in Regular Trading, mRNA Cancer Vaccine Theme Continues to Drive Momentum Amid Interim Turnaround

Market Focus
·
Sep 23

Movement Alert|CANSINOBIO Rises 5.25% in Regular Trading, mRNA Cancer Vaccine Theme Continues to Drive Momentum Amid Mid-Term Earnings Turnaround

Market Focus
·
Sep 22

Movement Alert|CANSINOBIO Rises 5.08% in Regular Trading, Interim Earnings Turnaround and Equity Incentive Plan Continue to Boost Sentiment

Market Focus
·
Sep 21

Movement Alert|CANSINOBIO Rises 6.86% in Regular Trading, H1 Earnings Turnaround and Equity Incentive Grant Boost Sentiment

Market Focus
·
Sep 18

Movement Alert|CANSINOBIO Rises 5.13% in Regular Trading, Equity Incentive Reserved Grant Lands Signaling Management Confidence

Market Focus
·
Sep 17

CanSino Biologics Allocates 287,400 Restricted Shares Under 2025 Incentive Scheme

Stock News
·
Sep 16

Movement Alert|CANSINOBIO Rises 5.12% in Regular Trading, Biotech Sector Strengthens Ahead of Upcoming Earnings Briefing

Market Focus
·
Sep 14

Movement Alert|CANSINOBIO Falls 5.51% in Regular Trading, Trading at HK$25.38

Market Focus
·
Sep 11

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
Sep 10

Movement Alert|CANSINOBIO Falls 5.09% in Regular Trading, Biotech Sector Broadly Weak as Post-Rally Profit-Taking Intensifies

Market Focus
·
Sep 10

Movement Alert|CANSINOBIO Rises 5.47% in Regular Trading, Strong H1 Results and mRNA Tumor Vaccine Catalyst Drive Gains

Market Focus
·
Sep 08

AH Premium Rankings Update: September 3 Market Close

Stock News
·
Sep 03

CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential

Deep News
·
Sep 02

AH Premium Rankings for September 2nd Market Close

Stock News
·
Sep 02

Movement Alert|CANSINOBIO Rises 7.93% in Regular Trading, CLSA Maintains Outperform Rating with 56% Upside Potential

Market Focus
·
Sep 02

AH Share Premium Rankings for September 1st

Stock News
·
Sep 01

CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.
·
Sep 01

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31